Two Red Cross volunteers have died from a suspected haemorrhagic fever in the Democratic Republic of Congo, raising urgent fears of a new Ebola outbreak in a region already scarred by the virus. Preliminary tests indicate the pathogen is likely the Zaire strain, the deadliest known form of Ebola, with a case fatality rate of up to 70 percent. The volunteers were involved in a burial team, handling deceased individuals from a community reporting multiple fever deaths in recent weeks.
The infections occurred in the northeastern province of North Kivu, close to the Ugandan border. This area was the epicentre of the 2018-2020 Ebola outbreak that claimed over 2,200 lives, the second largest in history. Health officials have now deployed rapid response teams, and the World Health Organization has escalated its alert level. Contact tracing has begun for at least 130 individuals who interacted with the volunteers or attended funerals where further exposures may have occurred.
The timing is alarming. The region also faces ongoing conflict, measles outbreaks, and the COVID-19 pandemic, all of which strain a fragile health system. The DR Congo has experienced 14 Ebola outbreaks since the virus was first discovered in 1976. Each resurgence tests the capacity of local and international responders. The greatest risk is amplification through funerals, where traditional washing of bodies increases transmission.
The volunteers were buried with strict safety protocols, but the delay in diagnosis and reporting raises concerns about undetected chains of transmission. The average incubation period for Ebola is 8 to 10 days, but can extend to 21 days. The next fortnight will be critical in determining whether this is an isolated cluster or the start of a wider epidemic.
Ebola spreads through direct contact with bodily fluids. Symptoms include sudden fever, fatigue, muscle pain, headache, and sore throat, followed by vomiting, diarrhoea, rash, and in severe cases, internal and external bleeding. There is no licensed treatment, but supportive care and experimental therapies can improve survival rates. The rVSV-ZEBOV vaccine, highly effective against the Zaire strain, is available. However, vaccination campaigns require a delicate logistical ballet of cold chains and community engagement.
The mortality of health workers is a devastating blow to the response. Their sacrifice highlights the immense courage of those on the front lines. The international community must mobilise resources rapidly to contain this outbreak before it spirals. As we have seen in past epidemics, speed is the only variable that matters. Every day of delay multiplies the potential for spread.
The natural world harbours these pathogens, and our encroachment into ecosystems increases spillover events. Climate change exacerbates this by altering habitats and human migration patterns. While the immediate focus is on saving lives, the long-term reckoning must address the root causes of zoonotic diseases.
For now, the eyes of the global health community are fixed on the DR Congo. The volunteers who died may have already purchased time with their lives. The question is whether we will use it wisely.
